Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resolving the Neurobiological Mechanisms of Anxiety Disorders - Brain Imaging Sub-study
2014-005366-30Phase 4Completed
- Sponsor
- University of Helsinki
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in Social Anxiety Disorder (SAD), sponsored by University of Helsinki. Started Jun 2016; status: completed.
02
Drugs
escitalopram
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on 2014-005366-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005366-30.